Funds · AXGT

Who owns AXGT?

No institutional manager reported a Axovant Gene Therapies Ltd. position in the latest Form 13F data we have. 13F covers US-listed shares held by managers with at least $100 million in such securities.

AXGT news and filings · Top funds